Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma

M. T. Bertero, M. De Maestri, F. Caligaris-Cappio

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We have used a combination of cyclosporin A and cyclophosphamide to treat a patient with multicentric Castleman's disease (MCD) complicated by visceral Kaposi's sarcoma (KS). Beneficial effects were observed on both MCD and KS lesions: the patient's clinical, radiological and laboratory findings have been stable for 27 months.

Original languageEnglish
Pages (from-to)216-217
Number of pages2
JournalHaematologica
Volume85
Issue number2
Publication statusPublished - 2000

Fingerprint

Kaposi's Sarcoma
Cyclophosphamide
Cyclosporine
Therapeutics
Multi-centric Castleman's Disease

Keywords

  • Castleman's disease
  • Kaposi's sarcoma
  • Treatment

ASJC Scopus subject areas

  • Hematology

Cite this

Bertero, M. T., De Maestri, M., & Caligaris-Cappio, F. (2000). Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma. Haematologica, 85(2), 216-217.

Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma. / Bertero, M. T.; De Maestri, M.; Caligaris-Cappio, F.

In: Haematologica, Vol. 85, No. 2, 2000, p. 216-217.

Research output: Contribution to journalArticle

Bertero, MT, De Maestri, M & Caligaris-Cappio, F 2000, 'Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma', Haematologica, vol. 85, no. 2, pp. 216-217.
Bertero, M. T. ; De Maestri, M. ; Caligaris-Cappio, F. / Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma. In: Haematologica. 2000 ; Vol. 85, No. 2. pp. 216-217.
@article{a07d050401e64bbcabf1f32e0d3c35d4,
title = "Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma",
abstract = "We have used a combination of cyclosporin A and cyclophosphamide to treat a patient with multicentric Castleman's disease (MCD) complicated by visceral Kaposi's sarcoma (KS). Beneficial effects were observed on both MCD and KS lesions: the patient's clinical, radiological and laboratory findings have been stable for 27 months.",
keywords = "Castleman's disease, Kaposi's sarcoma, Treatment",
author = "Bertero, {M. T.} and {De Maestri}, M. and F. Caligaris-Cappio",
year = "2000",
language = "English",
volume = "85",
pages = "216--217",
journal = "Haematologica",
issn = "0390-6078",
publisher = "NLM (Medline)",
number = "2",

}

TY - JOUR

T1 - Cyclophosphamide/cyclosporin-A treatment of multicentric Castleman's disease with Kaposi's sarcoma

AU - Bertero, M. T.

AU - De Maestri, M.

AU - Caligaris-Cappio, F.

PY - 2000

Y1 - 2000

N2 - We have used a combination of cyclosporin A and cyclophosphamide to treat a patient with multicentric Castleman's disease (MCD) complicated by visceral Kaposi's sarcoma (KS). Beneficial effects were observed on both MCD and KS lesions: the patient's clinical, radiological and laboratory findings have been stable for 27 months.

AB - We have used a combination of cyclosporin A and cyclophosphamide to treat a patient with multicentric Castleman's disease (MCD) complicated by visceral Kaposi's sarcoma (KS). Beneficial effects were observed on both MCD and KS lesions: the patient's clinical, radiological and laboratory findings have been stable for 27 months.

KW - Castleman's disease

KW - Kaposi's sarcoma

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=0034129916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034129916&partnerID=8YFLogxK

M3 - Article

VL - 85

SP - 216

EP - 217

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 2

ER -